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Introduction
Calcium overload induced by chronic administration of
the b-adrenoreceptor agonist, isoproterenol (IP), is used
in animal to study the mechanisms of cardiac hypertro-
phy and failure associated with a sustained increase in
circulating catecholamines.
Purpose
Time-dependent changes in myocardial perfusion,
morphologic and functional parameters were assessed in
rats in vivo using cardiac MRI. Energy metabolism and
nitric oxide (NO) pathway were evaluated in isolated
perfused rat hearts following 7 days of treatment.
Methods
Male Wistar rats were infused for 7 days via a subcutaneous
minipump containing isoproterenol (5 mg.kg-1 body
weight.day-1, IsoP group, n = 14) or vehicle (Control group,
n = 14). Three MRI in vivo examinations were performed
at day 1, 2 and 7 after pump implantation. A cine-MRI
sequence (FOV 4 cm, slice thickness 2 mm, matrix size
128*128, TE=1.2ms, TR=5.1 ms) and a gradient-echo FAIR
Look-Locker arterial spin labeling technique were used to
determine cardiac function and perfusion at all stages. For
ex vivo studies, isolated hearts were perfused with a physio-
logical buffer for 28 min before freeze-clamping for bio-
chemical assays. High energy phosphate compounds and
intracellular pH were followed using P-31 MRS with simul-
taneous measurement of contractile function. The total
creatine pool and malondialdehyde (MDA) content were
measured by HPLC. NO pathway was evaluated by
endothelial NO synthase expression and total nitrate con-
centration (NOx).
Results
Left ventricular mass was increased in IsoP after 1 day
and then maintained (p<0.05). Diastolic wall thickness
was increased in IsoP with a peak at day 2 and a return
to basal value at day 7 (p<0.05). Myocardial blood flow
was increased at day 1 in IsoP group and returned to
baseline values between days 1 and 2 (p<0.05). After 7
days of treatment, cardiac function in explanted hearts
was reduced by 36 % in IsoP (p<0.05 vs Control). PCr/
ATP ratio was lower (p<0.05) in IsoP (1.2±0.1) compared
with Control (1.7±0.1). MDA content was higher in IsoP
(p<0.05) compared with Control. eNOS expression and
NOx were increased in IsoP (p<0.05 vs Control).
Conclusions
IP increases myocardial perfusion and induces mor-
phological changes in the heart within the first 24
hours of administration. In addition, cardiac hypertro-
phy and decreased cardiac function were associated
with impaired phosphocreatine level, increased oxida-
tive stress and up-regulation of the NO pathway.
These results could lead to a better understanding of
the initial steps involved in cardiac hypertrophy and
failure.
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